HK Stock MarketDetailed Quotes

CHINARES PHARMA (03320)

Watchlist

4.550
-0.070-1.52%

Trading Jan 16 14:33 CST

28.59BMarket Cap9.23P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CHINARES PHARMA (03320) Income Statement

All

YOY

Hide blank lines

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

Turnover

2.54%131.87B

5.30%257.67B

4.71%128.6B

12.16%244.7B

-2.31%122.82B

-7.86%218.18B

9.81%125.72B

18.15%236.81B

28.08%114.49B

-1.97%200.42B

Operating income

2.54%131.87B

5.30%257.67B

4.71%128.6B

12.16%244.7B

-2.31%122.82B

-7.86%218.18B

9.81%125.72B

18.15%236.81B

28.08%114.49B

-1.97%200.42B

Cost of sales

-2.50%-110.36B

-5.15%-216.98B

-4.47%-107.66B

-11.81%-206.37B

2.67%-103.06B

8.37%-184.56B

-9.13%-105.88B

-19.80%-201.43B

-30.20%-97.02B

1.35%-168.13B

Operating expenses

-2.50%-110.36B

-5.15%-216.98B

-4.47%-107.66B

-11.81%-206.37B

2.67%-103.06B

8.37%-184.56B

-9.13%-105.88B

-19.80%-201.43B

-30.20%-97.02B

1.35%-168.13B

Gross profit

2.75%21.51B

6.13%40.69B

5.94%20.93B

14.04%38.34B

-0.36%19.76B

-4.98%33.62B

13.55%19.83B

9.56%35.38B

17.48%17.47B

-5.07%32.29B

Selling expenses

-6.74%-10.01B

-4.76%-19.81B

-1.49%-9.38B

-15.34%-18.91B

-1.80%-9.24B

6.48%-16.4B

-9.59%-9.08B

-9.37%-17.53B

-22.35%-8.28B

16.46%-16.03B

Administrative expenses

-4.67%-3.19B

-6.31%-6.73B

-7.00%-3.04B

-13.44%-6.33B

2.98%-2.85B

10.55%-5.58B

-8.58%-2.93B

-12.07%-6.24B

-25.74%-2.7B

-6.93%-5.56B

Operating interest expense

----

7.39%-1.36B

12.96%-2.74B

5.32%-1.47B

15.06%-3.15B

Special items of operating profit

-48.70%-1.28B

-8.23%-1.99B

-110.78%-857.54M

2.47%-1.84B

-542.26%-406.85M

-143.49%-1.88B

-540.76%-63.35M

-14.13%-773.81M

-28.30%14.37M

-215.67%-677.99M

Operating profit

-8.04%7.04B

8.00%12.16B

5.31%7.65B

15.37%11.26B

13.64%7.27B

20.58%9.76B

27.31%6.4B

17.85%8.09B

13.80%5.02B

5.69%6.87B

Financing income

-27.11%271.28M

15.90%681.1M

59.52%372.15M

-18.51%587.69M

--233.3M

--721.18M

----

Financing cost

14.58%-1.01B

4.38%-2.28B

17.60%-1.18B

2.74%-2.39B

---1.43B

---2.45B

----

Share of profits of associates

-43.03%113.24M

-11.77%368.01M

-6.25%198.77M

25.51%417.11M

14.04%212.01M

5.98%332.34M

30.26%185.91M

51.60%313.6M

89.37%142.73M

47.31%206.85M

Earning before tax

-8.94%6.42B

10.62%10.93B

12.14%7.05B

18.17%9.88B

-4.53%6.28B

-0.56%8.36B

27.39%6.58B

18.84%8.41B

15.07%5.17B

6.57%7.08B

Tax

9.51%-1.36B

-20.02%-2.53B

-20.05%-1.51B

-23.61%-2.11B

11.23%-1.25B

3.29%-1.7B

-31.85%-1.41B

-0.52%-1.76B

-27.28%-1.07B

-13.63%-1.75B

After-tax profit from continuing operations

-8.79%5.05B

8.08%8.4B

10.17%5.54B

16.78%7.78B

-2.69%5.03B

0.16%6.66B

26.23%5.17B

24.87%6.65B

12.25%4.09B

4.43%5.32B

Earning after tax

-8.79%5.05B

8.08%8.4B

10.17%5.54B

16.78%7.78B

-2.69%5.03B

0.16%6.66B

26.23%5.17B

24.87%6.65B

12.25%4.09B

4.43%5.32B

Minority profit

1.38%2.98B

28.86%5.05B

25.06%2.94B

24.17%3.92B

9.53%2.35B

9.70%3.16B

29.40%2.14B

42.04%2.88B

54.71%1.66B

11.88%2.03B

Profit attributable to shareholders

-20.25%2.08B

-13.06%3.35B

-2.87%2.6B

10.11%3.85B

-11.35%2.68B

-7.13%3.5B

24.07%3.03B

14.31%3.77B

-5.40%2.44B

0.33%3.3B

Basic earnings per share

-19.51%0.33

-13.11%0.53

-4.65%0.41

8.93%0.61

-10.42%0.43

-6.67%0.56

23.08%0.48

15.38%0.6

-4.88%0.39

0.00%0.52

Diluted earnings per share

-19.51%0.33

-13.11%0.53

-4.65%0.41

8.93%0.61

-10.42%0.43

-6.67%0.56

23.08%0.48

15.38%0.6

-4.88%0.39

0.00%0.52

Currency Unit

CNY

HKD

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

KPMG

Ernst & Young

Ernst & Young Accounting Firm

	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020
Turnover	2.54%131.87B	5.30%257.67B	4.71%128.6B	12.16%244.7B	-2.31%122.82B	-7.86%218.18B	9.81%125.72B	18.15%236.81B	28.08%114.49B	-1.97%200.42B
Operating income	2.54%131.87B	5.30%257.67B	4.71%128.6B	12.16%244.7B	-2.31%122.82B	-7.86%218.18B	9.81%125.72B	18.15%236.81B	28.08%114.49B	-1.97%200.42B
Cost of sales	-2.50%-110.36B	-5.15%-216.98B	-4.47%-107.66B	-11.81%-206.37B	2.67%-103.06B	8.37%-184.56B	-9.13%-105.88B	-19.80%-201.43B	-30.20%-97.02B	1.35%-168.13B
Operating expenses	-2.50%-110.36B	-5.15%-216.98B	-4.47%-107.66B	-11.81%-206.37B	2.67%-103.06B	8.37%-184.56B	-9.13%-105.88B	-19.80%-201.43B	-30.20%-97.02B	1.35%-168.13B
Gross profit	2.75%21.51B	6.13%40.69B	5.94%20.93B	14.04%38.34B	-0.36%19.76B	-4.98%33.62B	13.55%19.83B	9.56%35.38B	17.48%17.47B	-5.07%32.29B
Selling expenses	-6.74%-10.01B	-4.76%-19.81B	-1.49%-9.38B	-15.34%-18.91B	-1.80%-9.24B	6.48%-16.4B	-9.59%-9.08B	-9.37%-17.53B	-22.35%-8.28B	16.46%-16.03B
Administrative expenses	-4.67%-3.19B	-6.31%-6.73B	-7.00%-3.04B	-13.44%-6.33B	2.98%-2.85B	10.55%-5.58B	-8.58%-2.93B	-12.07%-6.24B	-25.74%-2.7B	-6.93%-5.56B
Operating interest expense	----	----	----	----	----	----	7.39%-1.36B	12.96%-2.74B	5.32%-1.47B	15.06%-3.15B
Special items of operating profit	-48.70%-1.28B	-8.23%-1.99B	-110.78%-857.54M	2.47%-1.84B	-542.26%-406.85M	-143.49%-1.88B	-540.76%-63.35M	-14.13%-773.81M	-28.30%14.37M	-215.67%-677.99M
Operating profit	-8.04%7.04B	8.00%12.16B	5.31%7.65B	15.37%11.26B	13.64%7.27B	20.58%9.76B	27.31%6.4B	17.85%8.09B	13.80%5.02B	5.69%6.87B
Financing income	-27.11%271.28M	15.90%681.1M	59.52%372.15M	-18.51%587.69M	--233.3M	--721.18M	----	----	----	----
Financing cost	14.58%-1.01B	4.38%-2.28B	17.60%-1.18B	2.74%-2.39B	---1.43B	---2.45B	----	----	----	----
Share of profits of associates	-43.03%113.24M	-11.77%368.01M	-6.25%198.77M	25.51%417.11M	14.04%212.01M	5.98%332.34M	30.26%185.91M	51.60%313.6M	89.37%142.73M	47.31%206.85M
Earning before tax	-8.94%6.42B	10.62%10.93B	12.14%7.05B	18.17%9.88B	-4.53%6.28B	-0.56%8.36B	27.39%6.58B	18.84%8.41B	15.07%5.17B	6.57%7.08B
Tax	9.51%-1.36B	-20.02%-2.53B	-20.05%-1.51B	-23.61%-2.11B	11.23%-1.25B	3.29%-1.7B	-31.85%-1.41B	-0.52%-1.76B	-27.28%-1.07B	-13.63%-1.75B
After-tax profit from continuing operations	-8.79%5.05B	8.08%8.4B	10.17%5.54B	16.78%7.78B	-2.69%5.03B	0.16%6.66B	26.23%5.17B	24.87%6.65B	12.25%4.09B	4.43%5.32B
Earning after tax	-8.79%5.05B	8.08%8.4B	10.17%5.54B	16.78%7.78B	-2.69%5.03B	0.16%6.66B	26.23%5.17B	24.87%6.65B	12.25%4.09B	4.43%5.32B
Minority profit	1.38%2.98B	28.86%5.05B	25.06%2.94B	24.17%3.92B	9.53%2.35B	9.70%3.16B	29.40%2.14B	42.04%2.88B	54.71%1.66B	11.88%2.03B
Profit attributable to shareholders	-20.25%2.08B	-13.06%3.35B	-2.87%2.6B	10.11%3.85B	-11.35%2.68B	-7.13%3.5B	24.07%3.03B	14.31%3.77B	-5.40%2.44B	0.33%3.3B
Basic earnings per share	-19.51%0.33	-13.11%0.53	-4.65%0.41	8.93%0.61	-10.42%0.43	-6.67%0.56	23.08%0.48	15.38%0.6	-4.88%0.39	0.00%0.52
Diluted earnings per share	-19.51%0.33	-13.11%0.53	-4.65%0.41	8.93%0.61	-10.42%0.43	-6.67%0.56	23.08%0.48	15.38%0.6	-4.88%0.39	0.00%0.52
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	HKD	HKD	HKD	HKD
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion
Auditor	--	KPMG	--	KPMG	--	Ernst & Young	--	Ernst & Young Accounting Firm	--	Ernst & Young Accounting Firm

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

No. Symbol 5D % Chg

Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.

Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde Show More

年頭旺到年尾

Aug 21, 2025 06:11

Are you foolish? What's the point of knowing your mistakes?

牛牛課堂

Sep 12, 2025 17:29

[Opportunity Express] With stock prices soaring, should SMIC "take profits and exit" or "patiently hold on"?